This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Beta-sitosterol plant extract in treatment of benign prostatic hyperplasia

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Authors of a systematic review concluded (1):

  • evidence suggests non-glucosidic Beta-sitosterols improve urinary symptoms and flow measures. Their long term effectiveness, safety and ability to prevent benign prostatic hyperplasia (BPH) complications are not known

A Clinical Evidence review categorised beta-sitosterol plant extract as a treatment modality likely to be beneficial in BPH


  1. Wilt T et al. Beta-sitosterols for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2000;(2):CD001043
  2. Clinical Evidence (April 2006). Benign Prostatic Hyperplasia.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.


Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.